# Itraconazole in Non Small Cell Lung Cancer

> **NCT03664115** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Itraconazole 200 mg
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03664115
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-02
- **Primary completion:** 2019-12-02
- **Final completion:** 2020-12-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664115, "Itraconazole in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03664115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*